Senior Associate Dean for Clinical Sciences
Co-Director, Clinical and Translational Science Institute
Director, Cardiovascular Clinical Research Center
Associate Director, Leon H Charney Division of Cardiology, Department of Medicine 

Dr. Hochman is considered one of the world's leading cardiovascular clinical trialists. In 2003 she directed the establishment of the Cardiovascular Clinical Research Center, which serves as the clinical coordinating center for international and national multi-center trials, as well as the organizing entity for numerous local trials.

Associate Dean, Translational Science
Director, Clinical and Translational Science Institute
Vice Chair for Strategy, Department of Radiology

Dr. Bredella served on the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) Program Steering Committee and chairs several national CTSA working groups. She also serves on the board of directors and executive committee of the Academy of Radiology Research, which played a key role in establishing the National Institute of Biomedical Imaging and Bioengineering.

Associate Dean, Clinical Research Strategy
Director, Interdisciplinary Melanoma Cooperative Group 

Dr. Iman Osman has more than 20 years of experience in translational research and holds 7 patents focused on biomarker development. She serves as the Director of the Interdisciplinary Melanoma program and the NCI-funded Melanoma Specialized Program of Research Excellence (SPORE). She also oversees the Center for Biospecimen Research and Development (CBRD), and works closely with OSR leadership to define the strategic priorities for clinical and translational research at NYU.

Director, Division of Biostatistics
Professor, Department of Population Health

Dr. Troxel has extensive experience in the design, conduct, and analysis of all phases of clinical studies and has published on missing data, sensitivity analyses, and statistical methodology for analysis of clinical trials. She is an expert on randomized trials of behavioral interventions and adaptive trial designs, with special focus on pragmatic trials and hybrid effectiveness/implementation studies.

Professor, Department of Population Health 

Dr. Yu is experienced at designing and implementing phase I, II, and III clinical trials, including for drug development, and conducting efficacy, safety, and pharmacokinetic analyses to support new drug application filings to the FDA. He has served as a principal investigator for multiple randomized controlled trials and associated data coordinating centers.